课题基金 / 基金详情

DIAGNOSIS AND CD5+ BETA CELLS IN PSYCHIATRIC PATIENTS

DIAGNOSIS AND CD5+ BETA CELLS IN PSYCHIATRIC PATIENTS
精神病患者的诊断和 CD5 Beta 细胞
批准号:
3845381
负责人:
D GLOVINSKY
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

D GLOVINSKY的其他基金

相似基金

相关文献

中文摘要
翻译
CD5+ β淋巴细胞亚群,它与几个
英文摘要
The CD5+ beta-lymphocyte subpopulation, which has been linked to several autoimmune diseases, has been reported to be increased in a subset of schizophrenic patients. To test the specificity of this finding, we measured the CD5+ beta-lymphocyte percentage of total lymphocytes in blood samples from 81 community mental health center patients and 10 controls. Results were analyzed according to diagnosis. The CD5+ beta-cell percentage in the substance abuser group was significantly elevated in comparison to all other groups. The percentage in the schizophrenic group was higher than the control group, but this increase was not statistically significant.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
PATIENT RESPONSE TO RESUMPTION OF NEUROLEPTICS FOLLOWING A DRUG FREE INTERVAL
CEREBROSPINAL FLUID OXYTOCIN IN SCHIZOPHRENIC AND CONTROL SUBJECT
PATIENT RESPONSE TO RESUMPTION OF NEUROLEPTIC FOLLOWING A DRUG FREE INTERVAL
SCREENING BRAIN DNA FOR HTLV-1 PROVIRAL SEQUENCES USING PCR AMPLIFICATION
海外基金